Jonas Ghouse News Today

A large case-control study using genetic proxies for PCSK9 inhibitors may help alleviate concerns that the dyslipidemia agents could promote adverse cardiac remodeling and heart failure.

Denmark: A recent study, published in the Journal of the American Heart Association found that HMG-CoA reductase inhibition (the target of statins) is associated with a high risk of cataract...

According to the findings of a recent study, individuals with genetic variations linked to statin medications appear to have an increased risk of developing cataracts and having cataract surgery.

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

According to findings in people with mutations in the target gene for statins, long-term use of the cholesterol lowering drugs may increase a person's risk for cataracts.

Get latest articles and stories on Science at LatestLY. People who have genetic variations associated with lowering LDL cholesterol similar to statin medications appear to have an increased risk of developing cataracts and having cataract surgery, according to new research. Science News | Cholesterol-lowering Gene Changes Might Increase Cataract Risk: Research.